Cargando…
Application of a Pharmacogenetics-Based Precision Medicine Model (5SPM) to Psychotic Patients That Presented Poor Response to Neuroleptic Therapy
Antipsychotics are the keystone of the treatment of severe and prolonged mental disorders. However, there are many risks associated with these drugs and not all patients undergo full therapeutic profit from them. The application of the 5 Step Precision Medicine model(5SPM), based on the analysis of...
Autores principales: | Carrascal-Laso, Lorena, Franco-Martín, Manuel Ángel, García-Berrocal, María Belén, Marcos-Vadillo, Elena, Sánchez-Iglesias, Santiago, Lorenzo, Carolina, Sánchez-Martín, Almudena, Ramos-Gallego, Ignacio, García-Salgado, M Jesús, Isidoro-García, María |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767089/ https://www.ncbi.nlm.nih.gov/pubmed/33352925 http://dx.doi.org/10.3390/jpm10040289 |
Ejemplares similares
-
Economic Impact of the Application of a Precision Medicine Model (5SPM) on Psychotic Patients
por: Carrascal-Laso, Lorena, et al.
Publicado: (2021) -
Case Report: Pharmacogenetics Applied to Precision Psychiatry Could Explain the Outcome of a Patient With a New CYP2D6 Genotype
por: Marcos-Vadillo, Elena, et al.
Publicado: (2022) -
Review: Influence of the CYP450 Genetic Variation on the Treatment of Psychotic Disorders
por: Carrascal-Laso, Lorena, et al.
Publicado: (2021) -
Ten Years of Experience Support Pharmacogenetic Testing to Guide Individualized Drug Therapy
por: Peña-Martín, María Celsa, et al.
Publicado: (2022) -
Role of Pharmacogenetics in Improving the Safety of Psychiatric Care by Predicting the Potential Risks of Mania in CYP2D6 Poor Metabolizers Diagnosed With Bipolar Disorder
por: Sánchez-Iglesias, Santiago, et al.
Publicado: (2016)